Dual-Antiplatelet Therapy: Why Stop Now?
JACC: Cardiovascular Interventions（2016）
摘要
Dual-antiplatelet therapy (DAPT), comprising a combination of aspirin with a P2Y12 receptor inhibitor, is prescribed following coronary stent implantation to reduce the risk for stent thrombosis and ischemic atherothrombotic events [(1,2)][1]. The recommended duration of DAPT is based on the type of
更多查看译文
关键词
dual-antiplatelet therapy,percutaneous coronary intervention,women
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要